Загрузка...

Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study

The goal of treatment in patients with pulmonary arterial hypertension is to achieve a low risk status, indicating a favorable long-term outcome. The REPLACE study investigated the efficacy of switching to riociguat in patients with pulmonary arterial hypertension and an insufficient response to pho...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Pulm Circ
Главные авторы: Simonneau, Gérald, Ghofrani, Hossein-Ardeschir, Corris, Paul A., Rosenkranz, Stephan, Grünig, Ekkehard, White, Jim, McLaughlin, Vallerie V., Langleben, David, Meier, Christian, Busse, Dennis, Kleinjung, Frank, Benza, Raymond L.
Формат: Artigo
Язык:Inglês
Опубликовано: SAGE Publications 2020
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7734510/
https://ncbi.nlm.nih.gov/pubmed/33354316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894020973124
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!